199 related articles for article (PubMed ID: 7659801)
1. [Use of GnRH analogs in hysteroscopic surgery].
Celis R
Rev Chil Obstet Ginecol; 1994; 59(2):153-7. PubMed ID: 7659801
[TBL] [Abstract][Full Text] [Related]
2. GnRH agonists before surgery for uterine leiomyomas. A review.
Crosignani PG; Vercellini P; Meschìa M; Oldani S; Bramante T
J Reprod Med; 1996 Jun; 41(6):415-21. PubMed ID: 8799917
[TBL] [Abstract][Full Text] [Related]
3. Treatment of uterine fibroids with GnRH-analogues prior to hysterectomy.
Stjernquist M
Acta Obstet Gynecol Scand Suppl; 1997; 164():94-7. PubMed ID: 9225649
[TBL] [Abstract][Full Text] [Related]
4. Benefit of GnRH analogue pretreatment for hysteroscopic surgery in patients with bleeding disorders.
Römer T
Gynecol Obstet Invest; 1998; 45 Suppl 1():12-20; discussion 21, 35. PubMed ID: 9628520
[TBL] [Abstract][Full Text] [Related]
5. Hysteroscopic endometrial ablation using the rollerball electrode.
Daniell JF; Kurtz BR; Ke RW
Obstet Gynecol; 1992 Sep; 80(3 Pt 1):329-32. PubMed ID: 1495687
[TBL] [Abstract][Full Text] [Related]
6. GnRH agonist analogs and hysteroscopic resection of myomas.
Mencaglia L; Tantini C
Int J Gynaecol Obstet; 1993 Dec; 43(3):285-8. PubMed ID: 7907039
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacological preparation of the endometrium in surgical hysteroscopy].
Primiero FM; Niccoli VS; Papale S
Clin Ter; 1996 May; 147(5):245-51. PubMed ID: 8766356
[TBL] [Abstract][Full Text] [Related]
8. Gonadotropin-releasing hormone agonist pretreatment did not decrease postoperative adhesion formation after abdominal myomectomy in a randomized control trial.
Coddington CC; Grow DR; Ahmed MS; Toner JP; Cook E; Diamond MP
Fertil Steril; 2009 May; 91(5):1909-13. PubMed ID: 18439584
[TBL] [Abstract][Full Text] [Related]
9. [GnRH agonists and antagonists in the preoperative therapy of uterine fibroids: literature review].
De Falco M; Pollio F; Pontillo M; Ambrosino E; Busiello A; Carbone IF; Ciociola F; Di Nardo MA; Landi L; Di Lieto A
Minerva Ginecol; 2006 Dec; 58(6):553-60. PubMed ID: 17108883
[TBL] [Abstract][Full Text] [Related]
10. [Use of GnGH (GnRH-A) in gynecology].
Ciardo A; Spina V; Aleandri V
Minerva Ginecol; 1998; 50(1-2):25-9. PubMed ID: 9577152
[TBL] [Abstract][Full Text] [Related]
11. [LH-RH analogues in the preparation of hysteroscopic resection of uterine fibromyoma].
Pace S; Labi FL; Lotti G; Mastrone M; Grassi A
Minerva Ginecol; 1992 May; 44(5):245-50. PubMed ID: 1608522
[TBL] [Abstract][Full Text] [Related]
12. Short-term and long-term results of resectoscopic myomectomy with and without pretreatment with GnRH analogs in premenopausal women.
Campo S; Campo V; Gambadauro P
Acta Obstet Gynecol Scand; 2005 Aug; 84(8):756-60. PubMed ID: 16026401
[TBL] [Abstract][Full Text] [Related]
13. Hormonal inhibition of the endometrium for resectoscopic endometrial ablation.
Brooks PG; Serden SP; Davos I
Am J Obstet Gynecol; 1991 Jun; 164(6 Pt 1):1601-6; discussion 1606-8. PubMed ID: 1904683
[TBL] [Abstract][Full Text] [Related]
14. [Results of hysteroscopic myomectomy].
Cravello L; Agostini A; Beerli M; Roger V; Bretelle F; Blanc B
Gynecol Obstet Fertil; 2004 Sep; 32(9):825-8. PubMed ID: 15380769
[TBL] [Abstract][Full Text] [Related]
15. The value of pre-operative treatment with GnRH analogues in women with submucous fibroids: a double-blind, placebo-controlled randomized trial.
Mavrelos D; Ben-Nagi J; Davies A; Lee C; Salim R; Jurkovic D
Hum Reprod; 2010 Sep; 25(9):2264-9. PubMed ID: 20663795
[TBL] [Abstract][Full Text] [Related]
16. Perioperative factors for predicting successful hysteroscopic endometrial ablation.
Gemer O; Kapustian V; Kroll D; Tur-Kaspa I; Segal S
J Reprod Med; 2003 Sep; 48(9):677-80. PubMed ID: 14562630
[TBL] [Abstract][Full Text] [Related]
17. Preoperative use of GnRH agonist for leiomyomas.
Hutchins FL
J Reprod Med; 1997 Apr; 42(4):253. PubMed ID: 9131502
[No Abstract] [Full Text] [Related]
18. Potential cost savings using GnRH agonists as preoperative therapy for uterine leiomyomas.
Saltiel E
Formulary; 1995 Sep; 30(9):532-4, 542. PubMed ID: 10161243
[TBL] [Abstract][Full Text] [Related]
19. Gonadotropin-releasing hormone agonist use before hysterectomy.
Stovall TG; Summit RL; Washburn SA; Ling FW
Am J Obstet Gynecol; 1994 Jun; 170(6):1744-8; discussion 1748-51. PubMed ID: 8203435
[TBL] [Abstract][Full Text] [Related]
20. Shrinkage effect of gonadotropin releasing hormone agonist treatment on uterine leiomyomas and t(12;14).
Takahashi K; Kawamura N; Ishiko O; Ogita S
Int J Oncol; 2002 Feb; 20(2):279-83. PubMed ID: 11788889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
